Recurrent pericarditis happens when inflammation of the heart’s protective sac returns after you’ve been symptom-free for at least 4 months. It affects up to 30% of people who experience acute ...
Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company advancing anti-inflammatory and anti-fibrotic therapies for heart disease, today ...
Recurrence is a serious complication of acute pericarditis. Recurrent pericarditis is a term used when a pericarditis patient relapses after discontinuation of treatment. It can also be described as a ...
Kiniksa Pharmaceuticals is anchored by Arcalyst, the only FDA-approved therapy for recurrent pericarditis, driving robust ...
Recurrent pericarditis occurred in one fifth of patients with systemic lupus erythematosus (SLE), with higher recurrence rates observed in younger patients and those receiving oral prednisone therapy.
Toronto, Ontario--(Newsfile Corp. - January 13, 2026) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company focused on advancing the ...
(HealthDay)—Use of anakinra reduces the risk of recurrence of pericarditis among patients with recurrent pericarditis with colchicine resistance and corticosteroid dependence, according to a study ...
Add Yahoo as a preferred source to see more of our stories on Google. Maintaining a daily routine is essential to living well when you have recurrent pericarditis. While it can feel as though ...
For people with recurrent pericarditis, travel can inspire mixed feelings of excitement and worry, largely due to the potential of experiencing a flare-up while away from home. Since symptoms of the ...
August 28, 2011 (Paris, France) — Italian researchers have shown that colchicine, when given in addition to conventional therapy, prevents recurrent episodes of pericarditis [1]. "Colchicine appears ...
Kiniksa Pharmaceuticals is set to begin a Phase 2/3 clinical trial for its drug KPL-387, aimed at treating recurrent pericarditis, in mid-2025. The company has noted that data from the ongoing Phase 1 ...
Recurrent pericarditis happens when inflammation of the pericardium (the protective sac around the heart) returns 4 or 6 weeks after the initial episode resolves. The most common symptom is sharp ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results